Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-26-000141
Filing Date
2026-02-27
Accepted
2026-02-27 16:49:43
Documents
1
Period of Report
2026-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4051
  Complete submission text file 0000904454-26-000141.txt   5575
Mailing Address 7358 MCVAY ROAD GERMANTOWN TN 38138
Business Address
Kapusta Matthew C (Reporting) CIK: 0001536290 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 26701147

Mailing Address PAASHEUVELWEG 25A AMSTERDAM Netherlands 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM Netherlands 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)